Painkillers Market Size

  • Report ID: 6691
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Painkillers Market Outlook:

Painkillers Market size was valued at USD 76.45 billion in 2025 and is likely to cross USD 114.26 billion by 2035, registering more than 4.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of painkillers is assessed at USD 79.27 billion.

The increasing availability of pain medicines through online and retail stores has propelled growth in this industry. With the integration of IoT and other connecting technologies in healthcare, their access to immediate and long-term pain-relieving medications has increased. This further contributes to the expansion by providing direct access to easily available options, particularly OTC products.

The surge in the painkillers market is also influenced by the growing population of aged people across the world. They often are diagnosed with chronic conditions such as osteoarthritis, arthritis, and other painful ailments, which require access to regular medication to offer relief. According to a WHO report published in October 2024, the global population of 60 years or more old people is expected to reach 2.1 billion by 2050. The number of 80-year-old people is also estimated to triple, accounting to be 426 million in 2050. This will increase the incidence rate of common painful diseases, creating a huge consumer base for pain medications and other relieving modalities.


Painkillers Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of painkillers is assessed at USD 79.27 billion.

The global painkillers market size was valued at over USD 76.45 billion in 2025 and is expected to register a CAGR of over 4.1%, exceeding USD 114.26 billion revenue by 2035.

North America painkillers market will account for 45.90% share by 2035, driven by rapid development in healthcare including pain management.

Key players in the market include Pfizer Inc., Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd..
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos